Phasebio Pharmaceuticals Inc (PHAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PHAS | AZN | AMGN | GILD | BMY |
| Company | Phasebio Pharmaceuticals Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.0800 | 174.60 | 327.98 | 127.59 | 54.56 |
| High | 0.0920 | 177.56 | 338.70 | 129.86 | 55.09 |
| Low | 0.0665 | 174.60 | 325.98 | 127.50 | 54.31 |
| Latest | 0.0701 | 176.28 | 338.22 | 128.99 | 54.72 |
| Change | -0.0249 | -1.17 | +9.96 | +1.42 | +0.26 |
| % Change | -26.21% | -0.66% | +3.03% | +1.11% | +0.48% |
| Volume | 9,647,400 | 2,396,900 | 2,289,300 | 6,237,100 | 11,540,600 |
| 20-Day Average Volume | 3,930,150 | 1,891,640 | 2,445,610 | 6,828,115 | 11,061,226 |
| Previous Close | 0.0950 | 177.45 | 328.26 | 127.57 | 54.46 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.1610 | 184.05 | 333.05 | 132.31 | 56.91 |
| 20-Day Raw Stochastic | 2.27% | 9.94% | 75.56% | 18.41% | 8.60% |
| 20-Day Relative Strength | 20.88 | 36.84 | 49.86 | 42.69 | 39.57 |
| Weighted Alpha | -91.26 | +13.74 | +14.07 | +10.94 | +11.59 |
| Today's Opinion | 100% Sell | 40% Sell | 24% Sell | 24% Sell | 24% Sell |
| Previous Opinion | 100% Sell | 40% Sell | 56% Sell | 40% Sell | 24% Sell |
| Last Month's Opinion | 72% Sell | 24% Buy | 24% Sell | 8% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -42.40% since 10/26/22 | -5.05% since 05/27/26 | +0.64% since 05/27/26 | -3.52% since 05/27/26 | -4.87% since 05/27/26 |
| Low | 0.0665 on 11/02/22 | 174.60 on 06/03/26 | 322.30 on 06/02/26 | 127.07 on 06/02/26 | 54.20 on 06/02/26 |
| High | 0.1440 on 10/27/22 | 187.10 on 05/29/26 | 338.70 on 06/03/26 | 137.20 on 05/29/26 | 57.69 on 05/28/26 |
| 1-Month | |||||
| %Chg | -60.17% since 09/30/22 | -4.58% since 05/01/26 | +2.55% since 05/01/26 | -2.02% since 05/01/26 | -6.01% since 05/01/26 |
| Low | 0.0665 on 11/02/22 | 174.60 on 06/03/26 | 320.52 on 05/05/26 | 127.07 on 06/02/26 | 54.20 on 06/02/26 |
| High | 0.2250 on 10/14/22 | 191.50 on 05/21/26 | 343.80 on 05/22/26 | 137.50 on 05/12/26 | 60.25 on 05/22/26 |
| 3-Month | |||||
| %Chg | -93.85% since 08/02/22 | -12.63% since 03/03/26 | -10.29% since 03/03/26 | -12.74% since 03/03/26 | -10.62% since 03/03/26 |
| Low | 0.0665 on 11/02/22 | 174.60 on 06/03/26 | 320.52 on 05/05/26 | 127.07 on 06/02/26 | 54.20 on 06/02/26 |
| High | 1.3800 on 08/09/22 | 207.30 on 04/10/26 | 380.14 on 03/11/26 | 149.38 on 03/10/26 | 62.58 on 03/04/26 |
| 6-Month | |||||
| %Chg | -94.35% since 05/02/22 | -2.98% since 12/03/25 | -2.08% since 12/03/25 | +3.19% since 12/03/25 | +7.38% since 12/03/25 |
| Low | 0.0665 on 11/02/22 | 174.60 on 06/03/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 50.22 on 12/04/25 |
| High | 1.3800 on 08/09/22 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,495 | 275,208,608 | 177,164,560 | 158,387,072 | 111,211,192 |
| Shares Outstanding, K | 49,858 | 1,550,908 | 539,708 | 1,241,570 | 2,042,071 |
| Annual Sales | 10,830,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -131,070,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 210,000 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -16,670,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 2.57 | 0.25 | 0.42 | 0.31 | 0.24 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.34 on 08/12/22 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 11/09/22 | 08/04/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.41 | 14.89 | 15.66 | 9.27 |